ArticleStroke (Hoboken, N.J.)2022
Mechanical Thrombectomy for Acute Ischemic Stroke in Patients With Dementia.
Article in Stroke (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Reperfusion therapies for ischemic stroke in dementia and cognitive impairment: A systematic review and meta-analysis.International journal of stroke : official journal of the International Stroke Society · 2024Pooled it
- Post-Thrombectomy Subarachnoid Hemorrhage: Incidence, Predictors, Clinical Relevance, and Effect Modulators.Diagnostics (Basel, Switzerland) · 2024Article
- Impact of reperfusion on thrombectomy outcomes in patients with pre-stroke disability.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To compare stroke severity, as well as usage and outcomes of mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in patients with and without dementia. Methods: Study of the US hospitalizations with AIS and documented National Institutes of Health Stroke Scale scores from October 1, 2016, to December 31, 2017. AIS hospitalizations with documented dementia were compared with AIS hospitalizations without dementia for stroke severity at onset, use of MT, and outcomes at discharge. Outcomes included favorable discharge disposition (home without assistance), in-hospital mortality, and radiographic intracranial hemorrhage. Results: Among 179 665 AIS admissions with recorded National Institutes of Health Stroke Scale score during the 15-month study period, 18 255 (10.2%) had preexisting dementia (62.5% women). The median age at stroke was 84 (interquartile range, 78-89) versus 69 (interquartile range, 59-79) years; and median presenting National Institutes of Health Stroke Scale score was 7 (interquartile range, 3-15) versus 4 (interquartile range, 2-10) in hospitalizations with versus without dementia. There was a stepwise association between increasing severity of the index stroke and the prevalence of dementia. In multivariable analysis, dementia was associated with significantly lower (odds ratio [OR], 0.43 [95% CI, 0.35-0.53]; Conclusion: One in 10 among all, and 1 in 4 among those aged ≥80 years had preexisting dementia at stroke onset. While patients with dementia were more likely to present with more severe deficits, MT was less frequently used in this population. Dementia was not independently associated with in-hospital mortality beyond stroke severity at onset, but increased the risk of intracranial hemorrhage following MT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.